Modelling SARS-CoV-2 Dynamics: Implications for Therapy
Kwang Su Kim, View ORCID ProfileKeisuke Ejima, Yusuke Ito, Shoya Iwanami, Hirofumi Ohashi, Yoshiki Koizumi, Yusuke Asai, Shinji Nakaoka, Koichi Watashi, Robin N. Thompson, Shingo Iwami
doi: https://doi.org/10.1101/2020.03.23.20040493
Kwang Su Kim
aDepartment of Biology, Faculty of Sciences, Kyushu University, Fukuoka, Japan 8190395
Keisuke Ejima
bDepartment of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, IN, USA 47405
Yusuke Ito
aDepartment of Biology, Faculty of Sciences, Kyushu University, Fukuoka, Japan 8190395
Shoya Iwanami
aDepartment of Biology, Faculty of Sciences, Kyushu University, Fukuoka, Japan 8190395
Hirofumi Ohashi
cDepartment of Virology II, National Institute of Infectious Diseases, Tokyo, Japan 1628640
Yoshiki Koizumi
dNational Center for Global Health and Medicine, Tokyo, Japan 1628655
Yusuke Asai
dNational Center for Global Health and Medicine, Tokyo, Japan 1628655
Shinji Nakaoka
eFaculty of Advanced Life Science, Hokkaido University, Sapporo, Japan 060-0808
fPRESTO, JST, Saitama, Japan 3320012
Koichi Watashi
cDepartment of Virology II, National Institute of Infectious Diseases, Tokyo, Japan 1628640
gDepartment of Applied Biological Science, Tokyo University of Science, Noda, Japan 2788510
hMIRAI, JST, Saitama, Japan 3320012
iCREST, JST, Saitama, Japan 3320012
jInstitute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan 6068507
Robin N. Thompson
kChrist Church, University of Oxford, Oxford OX1 1DP, UK
lMathematical Institute, University of Oxford, Oxford OX2 6GG, UK, Fukuoka, UK
Shingo Iwami
aDepartment of Biology, Faculty of Sciences, Kyushu University, Fukuoka, Japan 8190395
hMIRAI, JST, Saitama, Japan 3320012
iCREST, JST, Saitama, Japan 3320012
mScience Groove Inc., Fukuoka, Japan 8100041
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The data used in this study were extracted from the following papers: 1. Zou L, et al. (2020) SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2. Oh MD, et al. (2016) Viral Load Kinetics of MERS Coronavirus Infection. N Engl J Med 375(13):1303-1305. 3. Peiris JS, et al. (2003) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361(9371):1767-1772.
Posted March 27, 2020.
Modelling SARS-CoV-2 Dynamics: Implications for Therapy
Kwang Su Kim, Keisuke Ejima, Yusuke Ito, Shoya Iwanami, Hirofumi Ohashi, Yoshiki Koizumi, Yusuke Asai, Shinji Nakaoka, Koichi Watashi, Robin N. Thompson, Shingo Iwami
medRxiv 2020.03.23.20040493; doi: https://doi.org/10.1101/2020.03.23.20040493
Modelling SARS-CoV-2 Dynamics: Implications for Therapy
Kwang Su Kim, Keisuke Ejima, Yusuke Ito, Shoya Iwanami, Hirofumi Ohashi, Yoshiki Koizumi, Yusuke Asai, Shinji Nakaoka, Koichi Watashi, Robin N. Thompson, Shingo Iwami
medRxiv 2020.03.23.20040493; doi: https://doi.org/10.1101/2020.03.23.20040493
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12135)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4031)
- Geriatric Medicine (380)
- Health Economics (670)
- Health Informatics (2605)
- Health Policy (994)
- Hematology (359)
- HIV/AIDS (832)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3797)
- Nursing (208)
- Nutrition (564)
- Oncology (1989)
- Ophthalmology (577)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (249)
- Palliative Medicine (72)
- Pathology (470)
- Pediatrics (1098)
- Primary Care Research (443)
- Public and Global Health (6470)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (51)
- Transplantation (185)
- Urology (165)